Os02g0180000 Antibody

What is Os02g0180000 and what biological function does it serve?

Os02g0180000 is the gene identifier for OsAGO2 (ARGONAUTE 2) in rice. This protein plays critical roles in plant defense against viral invasion through epigenetic regulation mechanisms. OsAGO2 functions as a negative regulator of rice defense against rice black-streaked dwarf virus (RBSDV) infection by epigenetically controlling OsHXK1 expression . Specifically, OsAGO2 represses OsHXK1 expression via DNA methylation, which subsequently controls reactive oxygen species (ROS)-mediated resistance . Additionally, OsAGO2 has been shown to regulate ROS production and the timing of tapetal programmed cell death through epigenetic regulation .

What methodological approaches are used to detect Os02g0180000 expression in rice tissues?

Detection of Os02g0180000 (OsAGO2) expression can be accomplished through several approaches:

• RT-qPCR analysis: Most commonly used to quantify OsAGO2 transcript levels in different tissues or under various treatment conditions. Studies have shown OsAGO2 expression is induced upon RBSDV infection .

• Western blot analysis: Using specific antibodies against OsAGO2, researchers can detect protein levels. This typically involves:

  • Protein extraction from rice tissues using appropriate buffer systems

  • SDS-PAGE separation followed by transfer to membranes

  • Probing with primary OsAGO2 antibodies (typically at 0.5-2.0 μg/mL concentration)

  • Detection using appropriate secondary antibodies and visualization systems

• Immunohistochemistry: For localization studies to determine tissue-specific expression patterns, similar to approaches used for other plant proteins.

How can researchers validate the specificity of Os02g0180000 antibodies?

Validation of Os02g0180000 (OsAGO2) antibodies should follow these methodological approaches:

• Genetic knockout controls: Compare antibody signals between wild-type rice and Osago2 mutant lines (generated through transposon-insertion or CRISPR/Cas9 technology) . Absence of signal in mutant tissues confirms antibody specificity.

• Western blot analysis: Look for a single band of appropriate molecular weight. Multiple bands may indicate cross-reactivity with other AGO family members.

• Pre-absorption testing: Pre-incubate the antibody with purified recombinant OsAGO2 protein before use in assays; this should eliminate specific signals.

• Recombinant protein controls: Test antibody against E. coli-expressed recombinant OsAGO2 protein (similar to approaches used for other proteins like OSM) .

• Neutralization assays: For functional antibodies, determine the neutralization dose (ND50) against known OsAGO2 activity .

How can Os02g0180000 antibodies be used to study epigenetic regulation mechanisms in rice?

Os02g0180000 (OsAGO2) antibodies can facilitate several advanced epigenetic research applications:

• Chromatin Immunoprecipitation (ChIP):

  • Use OsAGO2 antibodies to identify genomic regions where OsAGO2 associates with chromatin

  • Particularly useful for investigating the mechanism by which OsAGO2 regulates OsHXK1 promoter methylation

• RNA Immunoprecipitation (RIP):

  • Identify RNA molecules that associate with OsAGO2 in vivo

  • Critical for understanding OsAGO2's role in gene silencing pathways

• Co-Immunoprecipitation (Co-IP):

  • Identify protein interaction partners of OsAGO2 in epigenetic regulation complexes

  • Can be used to study how OsAGO2 interacts with DNA methylation machinery

• Immunofluorescence microscopy:

  • Visualize the subcellular localization of OsAGO2 during viral infection

  • Track dynamics of OsAGO2 localization during response to pathogens

Research has shown that OsAGO2 regulates OsHXK1 expression through DNA methylation of its promoter region during RBSDV infection . OsAGO2 antibodies can help elucidate this mechanism by revealing where and when this protein acts during the infection process.

What experimental approaches can reveal the role of Os02g0180000 in rice antiviral defense mechanisms?

To investigate Os02g0180000 (OsAGO2) involvement in rice antiviral defense:

• Comparative immunoprecipitation studies:

  • Use OsAGO2 antibodies to pull down protein complexes from both healthy and virus-infected tissues

  • Mass spectrometry analysis to identify differential binding partners

  • Compare results between wild-type and Osago2 mutant lines

• Immunohistochemistry during infection progression:

  • Temporal and spatial localization of OsAGO2 during viral infection

  • Co-localization with viral components to identify direct interactions

• Small RNA immunoprecipitation:

  • Identify virus-derived small RNAs that associate with OsAGO2

  • Sequence analysis to determine if specific viral RNA regions are targeted

• ROS detection combined with immunolocalization:

  • Correlate OsAGO2 localization with ROS production in infected tissues

  • Important since OsAGO2 modulates rice susceptibility to fijivirus infection by suppressing OsHXK1 expression, which leads to ROS-mediated resistance

Data derived from findings reported in search result .

How can researchers investigate the interaction between Os02g0180000 and OsHXK1 using antibody-based approaches?

To study the regulatory relationship between Os02g0180000 (OsAGO2) and OsHXK1:

• Sequential ChIP (ChIP-reChIP):

  • First immunoprecipitate with OsAGO2 antibodies

  • Then perform a second immunoprecipitation with antibodies against DNA methylation markers

  • Identify regions where both OsAGO2 and methylation markers co-localize on the OsHXK1 promoter

• Proximity ligation assay (PLA):

  • Detect if OsAGO2 is in close proximity to DNA methyltransferases near the OsHXK1 promoter

  • Requires antibodies against both OsAGO2 and relevant methyltransferases

• Methylation-specific immunoprecipitation:

  • Compare OsHXK1 promoter methylation patterns between:

    • Wild-type plants

    • OsAGO2 overexpression lines

    • Osago2 mutant lines

  • Research has shown that compared to Nipponbare control, methylation levels of the OsHXK1 promoter decreased in the Osago2 mutant during RBSDV infection

• Dual immunofluorescence labeling:

  • Visualize the spatial relationship between OsAGO2 and OsHXK1 expression

  • Observe their expression patterns during RBSDV infection

What are the optimal conditions for using Os02g0180000 antibodies in Western blot applications?

For optimal Western blot results with Os02g0180000 (OsAGO2) antibodies:

• Sample preparation:

  • Extract proteins using buffer containing protease inhibitors to prevent degradation

  • For membrane-associated proteins, consider specialized extraction buffers

• Antibody dilution optimization:

  • Typically start with 0.5-2.0 μg/mL concentration similar to other research antibodies

  • Perform titration experiments to determine optimal concentration for specific antibody lot

• Blocking optimization:

  • Use 3-5% BSA or non-fat dry milk in TBS-T

  • For phospho-specific detection, BSA is preferred over milk

• Incubation conditions:

  • Primary antibody: 4°C overnight or 2 hours at room temperature

  • Secondary antibody: 1 hour at room temperature

• Washing steps:

  • Use TBS-T (TBS with 0.1% Tween-20)

  • Perform 3-5 washes of 5-10 minutes each between antibody incubations

• Signal development:

  • Choose detection method based on sensitivity requirements

  • For low abundance proteins, consider using enhanced chemiluminescence or fluorescent detection

How can researchers optimize immunoprecipitation protocols for Os02g0180000 in rice tissues?

For effective immunoprecipitation of Os02g0180000 (OsAGO2):

• Tissue preparation:

  • Use fresh tissue when possible

  • Flash-freeze and store at -70°C if immediate processing isn't possible

  • Grind tissue thoroughly in liquid nitrogen before adding lysis buffer

• Lysis buffer selection:

  • Include both ionic and non-ionic detergents

  • Add protease inhibitors, phosphatase inhibitors, and RNase inhibitors

  • For studying AGO-RNA interactions, use RNase inhibitors

• Pre-clearing step:

  • Incubate lysate with protein A/G beads before adding antibody

  • Reduces non-specific binding in final immunoprecipitation

• Antibody incubation:

  • Use 2-5 μg antibody per 500 μg of total protein

  • Incubate overnight at 4°C with gentle rotation

• Bead selection:

  • For monoclonal antibodies, match the beads to the antibody species and isotype

  • Consider using magnetic beads for gentler handling

• Washing stringency:

  • Multiple washes with decreasing detergent concentrations

  • Final washes in detergent-free buffer

• Elution conditions:

  • For western blot: direct elution in SDS sample buffer

  • For downstream applications requiring native protein: gentle elution with peptide competition

• Controls:

  • Include IgG control and input samples

  • For validation, use Osago2 mutant tissue as a negative control

What strategies can improve the specificity of Os02g0180000 antibodies in complex plant tissue samples?

To enhance specificity when using Os02g0180000 (OsAGO2) antibodies in complex samples:

• Antibody purification:

  • Consider using affinity-purified antibodies targeted to unique epitopes of OsAGO2

  • Avoid regions with homology to other AGO family members

• Blocking optimizations:

  • Add 1-5% normal serum from the species of the secondary antibody

  • Include 0.1-0.3% Triton X-100 to reduce hydrophobic interactions

• Pre-absorption strategies:

  • Pre-incubate antibodies with tissue lysates from Osago2 mutant plants

  • Removes antibodies that bind to proteins other than OsAGO2

• Cross-reactivity reduction:

  • Use monoclonal antibodies when available for highest specificity

  • For polyclonal antibodies, consider additional purification steps

• Signal validation approaches:

  • Compare signals between wild-type and Osago2 mutant tissues

  • Use multiple antibodies targeting different epitopes of OsAGO2

  • Include peptide competition controls

• Sample preparation optimization:

  • Remove phenolic compounds that can interfere with antibody binding

  • Consider using specialized extraction buffers designed for plant tissues

How should researchers design time-course experiments to study Os02g0180000 dynamics during viral infection?

For effective time-course studies of Os02g0180000 (OsAGO2) during viral infection:

• Sampling timeline optimization:

  • Include pre-infection baseline (0 hours)

  • Early response phase (6, 12, 24 hours post-infection)

  • Established infection phase (3, 5, 7 days post-infection)

  • Late/recovery phase (14, 21 days post-infection)

  • Base timing on findings that OsAGO2 expression is induced upon RBSDV infection

• Sample collection strategy:

  • Collect both local (infection site) and systemic tissues

  • Include paired samples for protein and RNA analysis from each timepoint

  • Preserve samples appropriately for multiple analysis methods

• Control considerations:

  • Include mock-infected controls at each timepoint

  • Consider including both wild-type and Osago2 mutant plants

  • Include OsAGO2 overexpression lines for complete expression spectrum

• Analytical approach:

  • Western blot with OsAGO2 antibodies to track protein levels

  • RT-qPCR to monitor transcript dynamics

  • ChIP to track changes in OsAGO2 interactions with OsHXK1 promoter

  • ROS measurements to correlate with resistance mechanisms

• Data integration:

  • Correlate OsAGO2 levels with viral titer

  • Map relationship between OsAGO2, OsHXK1 expression, and ROS production

  • Link molecular data to phenotypic disease progression

What approaches can be used to study post-translational modifications of Os02g0180000 using antibody-based techniques?

To investigate post-translational modifications (PTMs) of Os02g0180000 (OsAGO2):

• Phospho-specific antibody approaches:

  • Develop antibodies against predicted phosphorylation sites of OsAGO2

  • Use comparative Western blotting with and without phosphatase treatment

  • Apply phospho-enrichment before immunoprecipitation

• Two-dimensional gel electrophoresis with immunodetection:

  • Separate proteins by isoelectric point and molecular weight

  • Perform Western blotting with OsAGO2 antibodies

  • Multiple spots indicate presence of different PTM forms

• Immunoprecipitation coupled with mass spectrometry:

  • Use OsAGO2 antibodies to immunoprecipitate the protein

  • Analyze by mass spectrometry to identify:

    • Phosphorylation sites

    • Ubiquitination sites

    • SUMOylation sites

    • Other modifications

• Antibody-based PTM detection sequence:

  • First immunoprecipitate with OsAGO2 antibodies

  • Then probe with antibodies against specific modifications (phospho, ubiquitin, SUMO)

  • Compare modification patterns between healthy and virus-infected tissues

• Proximity ligation assays:

  • Detect in situ interaction between OsAGO2 and modifying enzymes

  • Useful for studying dynamic modifications during viral infection

How can researchers effectively combine immunodetection with ROS measurement techniques?

For dual analysis of Os02g0180000 (OsAGO2) and ROS in the same samples:

• Sequential tissue sampling approaches:

  • Split samples for parallel OsAGO2 immunodetection and ROS measurement

  • Ensure samples represent the same physiological state

  • Critical since OsAGO2 regulates ROS production via OsHXK1

• In situ co-detection methods:

  • Perform ROS staining (e.g., DAB, NBT, or H2DCFDA)

  • Follow with immunofluorescence for OsAGO2

  • Counterstain nuclei for cellular context

• Cell fractionation coupled with assays:

  • Separate cellular compartments (cytosol, membrane, nuclei)

  • Perform Western blot for OsAGO2 in each fraction

  • Measure ROS production in parallel fractions

• Genetic approach with reporter systems:

  • Use OsAGO2 antibodies in transgenic plants expressing ROS reporter constructs

  • Compare wild-type, Osago2 mutant, and OsAGO2 overexpression lines

• Time-resolved analysis:

  • Track OsAGO2 levels over time after viral infection

  • Correlate with ROS measurement at the same timepoints

  • Important since overexpression of OsHXK1 induces ROS production and enhances rice resistance to RBSDV infection

How can Os02g0180000 antibodies be adapted for bispecific detection applications?

Adapting Os02g0180000 (OsAGO2) antibodies for bispecific applications:

• Engineering bispecific antibodies:

  • Combine OsAGO2 binding domain with domains targeting:

    • Viral proteins for co-localization studies

    • DNA methylation enzymes to study epigenetic mechanisms

    • OsHXK1 for direct interaction studies

  • Consider symmetric (HC2LC2) formats for applications requiring bivalent binding

  • For monovalent targeting, different formats may be required

• Linker optimization:

  • Use glycine-serine linkers of 10-25 amino acids for fusion constructs

  • These provide favorable flexibility and stability in aqueous solutions

  • Alternate approach: use linkers derived from natural antibody hinge regions

• Development considerations:

  • Evaluate biophysical stability of engineered constructs

  • Test for potential aggregation during storage

  • Assess expression yields of different molecular geometries

• Application-specific designs:

  • For detection of protein complexes: bispecific formats targeting OsAGO2 and interaction partners

  • For studying pathway interactions: dual targeting of OsAGO2 and OsHXK1

What considerations should researchers make when developing antibodies against different domains of Os02g0180000?

When developing domain-specific antibodies against Os02g0180000 (OsAGO2):

• Domain-specific targeting strategy:

  • PAZ domain: Important for small RNA binding

  • PIWI domain: Contains catalytic residues

  • N-terminal region: Often involved in protein-protein interactions

  • Choose domains based on experimental objectives

• Epitope selection considerations:

  • Avoid highly conserved regions that may cross-react with other AGO proteins

  • Target surface-exposed regions for better accessibility

  • Consider selecting regions differentially modified during viral infection

• Antibody format selection:

  • Full IgG: Best for immunoprecipitation and Western blotting

  • Fab fragments: Better tissue penetration for immunohistochemistry

  • scFv: Useful for creating fusion proteins

  • Consider sdAbs (single-domain antibodies) for their small size and stability

• Validation approaches:

  • Test against recombinant domain fragments

  • Verify using domain deletion mutants

  • Confirm specificity against Osago2 mutant tissues

• Application optimization:

  • Different domain-specific antibodies may perform optimally in different applications

  • PAZ domain antibodies: Best for RNA-binding studies

  • PIWI domain antibodies: Preferred for functional studies

  • N-terminal antibodies: Optimal for protein interaction studies

By developing a panel of domain-specific antibodies, researchers can gain insights into different functional aspects of OsAGO2 during viral infection and defense responses.